메뉴 건너뛰기




Volumn 65, Issue 2, 2010, Pages 243-250

Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent d-19575 (glufosfamide) in patients with solid tumors

Author keywords

Glucose transporter; Glufosfamide; Isophosphoramide mustard; Pharmacokinetics

Indexed keywords

BETA 2 MICROGLOBULIN; CISPLATIN; CYTOTOXIC AGENT; FLUOROURACIL; GEMCITABINE; GLUFOSFAMIDE; IFOSFAMIDE; UNCLASSIFIED DRUG;

EID: 71349086204     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-1028-3     Document Type: Article
Times cited : (19)

References (26)
  • 1
    • 0033975038 scopus 로고    scopus 로고
    • Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent
    • 10.1054/bjoc.1999.0974 1:CAS:528:DC%2BD3cXht1eisb8%3D 10682676
    • H Seker B Bertram A Burkle B Kaina J Pohl H Koepsell M Wiesser 2000 Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent Br J Cancer 82 3 629 634 10.1054/bjoc.1999.0974 1:CAS:528:DC%2BD3cXht1eisb8%3D 10682676
    • (2000) Br J Cancer , vol.82 , Issue.3 , pp. 629-634
    • Seker, H.1    Bertram, B.2    Burkle, A.3    Kaina, B.4    Pohl, J.5    Koepsell, H.6    Wiesser, M.7
  • 2
    • 34247331011 scopus 로고    scopus 로고
    • Design of new oxazaphosphorine anticancer drugs
    • DOI 10.2174/138161207780414296
    • J Liang M Huang W Duan XQ Yu S Zhou 2007 Design of new oxazaphosphorine anticancer drugs Curr Pharm Des 13 9 963 978 10.2174/138161207780414296 1:CAS:528:DC%2BD2sXmtVWmurY%3D 17430192 (Pubitemid 46628292)
    • (2007) Current Pharmaceutical Design , vol.13 , Issue.9 , pp. 963-978
    • Liang, J.1    Huang, M.2    Duan, W.3    Yu, X.-Q.4    Zhou, S.5
  • 3
    • 0030023026 scopus 로고    scopus 로고
    • Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers
    • 1:CAS:528:DyaK28XhtlKkt7o%3D 8640778
    • M Younes LV Lechago JR Somoano M Mosharaf J Lechago 1996 Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers Cancer Res 56 5 1164 1167 1:CAS:528:DyaK28XhtlKkt7o%3D 8640778
    • (1996) Cancer Res , vol.56 , Issue.5 , pp. 1164-1167
    • Younes, M.1    Lechago, L.V.2    Somoano, J.R.3    Mosharaf, M.4    Lechago, J.5
  • 6
    • 0027505293 scopus 로고
    • Cloning and expression of a mammalian Na+/amino acid cotransporter with sequence similarity to Na+/glucose cotransporters
    • 1:CAS:528:DyaK3sXit1ymsLo%3D 8420925
    • CT Kong SF Yet JE Lever 1993 Cloning and expression of a mammalian Na+/amino acid cotransporter with sequence similarity to Na+/glucose cotransporters J Biol Chem 268 3 1509 1512 1:CAS:528:DyaK3sXit1ymsLo%3D 8420925
    • (1993) J Biol Chem , vol.268 , Issue.3 , pp. 1509-1512
    • Kong, C.T.1    Yet, S.F.2    Lever, J.E.3
  • 7
    • 0028021758 scopus 로고
    • SAAT1 is a low affinity Na+/glucose cotransporter and not an amino acid transporter. A reinterpretation
    • 1:CAS:528:DyaK2cXlvFylurg%3D 8077195
    • B Mackenzie M Panayotova-Heiermann DD Loo JE Lever EM Wright 1994 SAAT1 is a low affinity Na+/glucose cotransporter and not an amino acid transporter. A reinterpretation J Biol Chem 269 36 22488 22491 1:CAS:528:DyaK2cXlvFylurg%3D 8077195
    • (1994) J Biol Chem , vol.269 , Issue.36 , pp. 22488-22491
    • MacKenzie, B.1    Panayotova-Heiermann, M.2    Loo, D.D.3    Lever, J.E.4    Wright, E.M.5
  • 8
    • 0029679705 scopus 로고    scopus 로고
    • 3H]-thymidine in various tissues of the rat
    • DOI 10.1007/s002800050495
    • J Stuben R Port B Bertram U Bollow WE Hull M Schaper J Pohl M Wiessler 1996 Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-d-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat Cancer Chemother Pharmacol 38 4 355 365 10.1007/s002800050495 1:STN:280: DyaK283osFGrug%3D%3D 8674159 (Pubitemid 26226302)
    • (1996) Cancer Chemotherapy and Pharmacology , vol.38 , Issue.4 , pp. 355-365
    • Stuben, J.1    Port, R.2    Bertram, B.3    Bollow, U.4    Hull, W.E.5    Schaper, M.6    Pohl, J.7    Wiessler, M.8
  • 9
    • 59649125837 scopus 로고    scopus 로고
    • New ifosfamide analogues designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity
    • 10.1124/jpet.108.144170 1:CAS:528:DC%2BD1MXhs1Kgsrg%3D 19017849
    • T Storme A Deroussent L Mercier E Prost M Re F Munier T Martens P Bourget G Vassal J Royer 2009 New ifosfamide analogues designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity J Pharmacol Exp Ther 328 2 598 609 10.1124/jpet.108.144170 1:CAS:528:DC%2BD1MXhs1Kgsrg%3D 19017849
    • (2009) J Pharmacol Exp Ther , vol.328 , Issue.2 , pp. 598-609
    • Storme, T.1    Deroussent, A.2    Mercier, L.3    Prost, E.4    Re, M.5    Munier, F.6    Martens, T.7    Bourget, P.8    Vassal, G.9    Royer, J.10
  • 10
    • 0141594797 scopus 로고    scopus 로고
    • Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group
    • DOI 10.1016/S0959-8049(03)00629-4
    • E Briasoulis N Pavlidis C Terret J Bauer W Fiedler P Schoffski JL Raoul D Hess R Selvais D Lacombe 2003 Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group Eur J Cancer 39 16 2334 2340 10.1016/S0959-8049(03)00629-4 1:CAS:528:DC%2BD3sXnvVymtbY%3D 14556925 (Pubitemid 37214857)
    • (2003) European Journal of Cancer , vol.39 , Issue.16 , pp. 2334-2340
    • Briasoulis, E.1    Pavlidis, N.2    Terret, C.3    Bauer, J.4    Fiedler, W.5    Schoffski, P.6    Raoul, J.-L.7    Hess, D.8    Selvais, R.9    Lacombe, D.10    Bachmann, P.11    Fumoleau, P.12
  • 11
    • 12144285603 scopus 로고    scopus 로고
    • Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer: A phase II trial of the EORTC-New Drug Development Group
    • DOI 10.1016/j.ejca.2003.10.027, PII S0959804903010232
    • G Giaccone EF Smit M de Jonge E Dansin E Briasoulis A Ardizzoni JY Douillard D Spaeth D Lacombe B Baron 2004 Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group Eur J Cancer 40 5 667 672 10.1016/j.ejca.2003.10.027 1:CAS:528:DC%2BD2cXhvVOrt7c%3D 15010066 (Pubitemid 38326615)
    • (2004) European Journal of Cancer , vol.40 , Issue.5 , pp. 667-672
    • Giaccone, G.1    Smit, E.F.2    De Jonge, M.3    Dansin, E.4    Briasoulis, E.5    Ardizzoni, A.6    Douillard, J.-Y.7    Spaeth, D.8    Lacombe, D.9    Baron, B.10    Bachmann, P.11    Fumoleau, P.12
  • 12
    • 0034667838 scopus 로고    scopus 로고
    • Phase i trial of 6-h infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: A study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group
    • 1:CAS:528:DC%2BD3cXnvV2kurk%3D 11032596
    • E Briasoulis I Judson N Pavlidis P Beale J Wanders Y Groot G Veerman M Schuessler G Niebch K Siamopoulos 2000 Phase I trial of 6-h infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: a study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group J Clin Oncol 18 20 3535 3544 1:CAS:528:DC%2BD3cXnvV2kurk%3D 11032596
    • (2000) J Clin Oncol , vol.18 , Issue.20 , pp. 3535-3544
    • Briasoulis, E.1    Judson, I.2    Pavlidis, N.3    Beale, P.4    Wanders, J.5    Groot, Y.6    Veerman, G.7    Schuessler, M.8    Niebch, G.9    Siamopoulos, K.10
  • 14
    • 0034053590 scopus 로고    scopus 로고
    • Metabolism and pharmacokinetics of oxazaphosphorines
    • 10.2165/00003088-200038040-00001 1:CAS:528:DC%2BD3cXjtlKku7s%3D 10803453
    • AV Boddy SM Yule 2000 Metabolism and pharmacokinetics of oxazaphosphorines Clin Pharmacokinet 38 4 291 304 10.2165/00003088-200038040- 00001 1:CAS:528:DC%2BD3cXjtlKku7s%3D 10803453
    • (2000) Clin Pharmacokinet , vol.38 , Issue.4 , pp. 291-304
    • Boddy, A.V.1    Yule, S.M.2
  • 15
    • 0029011183 scopus 로고
    • Comparison of continuous infusion and bolus administration of ifosfamide in children
    • 10.1016/0959-8049(95)00090-6 1:STN:280:DyaK2MzmsleitA%3D%3D 7640054
    • AV Boddy SM Yule R Wyllie L Price AD Pearson JR Idle 1995 Comparison of continuous infusion and bolus administration of ifosfamide in children Eur J Cancer 31A 5 785 790 10.1016/0959-8049(95)00090-6 1:STN:280:DyaK2MzmsleitA%3D%3D 7640054
    • (1995) Eur J Cancer , vol.31 , Issue.5 , pp. 785-790
    • Boddy, A.V.1    Yule, S.M.2    Wyllie, R.3    Price, L.4    Pearson, A.D.5    Idle, J.R.6
  • 16
    • 0029891049 scopus 로고    scopus 로고
    • Glucose catabolism in cancer cells: Amplification of the gene encoding type II hexokinase
    • A Rempel SP Mathupala CA Griffin AL Hawkins PL Pedersen 1996 Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase Cancer Res 56 11 2468 2471 1:CAS:528:DyaK28XjtlCgt7c%3D 8653677 (Pubitemid 26170674)
    • (1996) Cancer Research , vol.56 , Issue.11 , pp. 2468-2471
    • Rempel, A.1    Mathupala, S.P.2    Griffin, C.A.3    Hawkins, A.L.4    Pedersen, P.L.5
  • 17
    • 0019977934 scopus 로고
    • Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients
    • DOI 10.1002/1097-0142(19820915)50:6<1142::AID-CNCR2820500618>3.0. CO;2-I
    • K Lundholm S Edstrom I Karlberg L Ekman T Schersten 1982 Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients Cancer 50 6 1142 1150 10.1002/1097-0142(19820915)50: 6<1142::AID-CNCR2820500618>3.0.CO;2-I 1:STN:280:DyaL383lvVyitw%3D%3D 7104955 (Pubitemid 12062893)
    • (1982) Cancer , vol.50 , Issue.6 , pp. 1142-1150
    • Lundholm, K.1    Edstrom, S.2    Karlberg, I.3
  • 18
    • 0026770338 scopus 로고
    • Glucose transporters
    • 10.1146/annurev.me.43.020192.002113 1:CAS:528:DyaK38XkvVOmtb0%3D 1580597
    • LJ Elsas N Longo 1992 Glucose transporters Annu Rev Med 43 377 393 10.1146/annurev.me.43.020192.002113 1:CAS:528:DyaK38XkvVOmtb0%3D 1580597
    • (1992) Annu Rev Med , vol.43 , pp. 377-393
    • Elsas, L.J.1    Longo, N.2
  • 19
    • 0027948971 scopus 로고
    • Molecular physiology of sodium-glucose cotransporters
    • 1:CAS:528:DyaK2MXitFGnsLs%3D 7938229
    • MA Hediger DB Rhoads 1994 Molecular physiology of sodium-glucose cotransporters Physiol Rev 74 4 993 1026 1:CAS:528:DyaK2MXitFGnsLs%3D 7938229
    • (1994) Physiol Rev , vol.74 , Issue.4 , pp. 993-1026
    • Hediger, M.A.1    Rhoads, D.B.2
  • 20
    • 0027489912 scopus 로고
    • Overexpression of Glut-1 glucose transporter in human breast cancer: An immunohistochemical study
    • DOI 10.1002/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0. CO;2-X
    • RS Brown RL Wahl 1993 Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study Cancer 72 10 2979 2985 10.1002/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO;2-X 1:STN:280:DyaK2c%2Fjs1KqtA%3D%3D 8221565 (Pubitemid 23335044)
    • (1993) Cancer , vol.72 , Issue.10 , pp. 2979-2985
    • Brown, R.S.1    Wahl, R.L.2
  • 21
    • 0031825144 scopus 로고    scopus 로고
    • Role for glucose transporter 1 protein in human breast cancer
    • 10.1007/BF02904704 1:CAS:528:DyaK1cXlvFOmsLk%3D 9654596
    • M Grover-McKay SA Walsh EA Seftor PA Thomas MJ Hendrix 1998 Role for glucose transporter 1 protein in human breast cancer Pathol Oncol Res 4 2 115 120 10.1007/BF02904704 1:CAS:528:DyaK1cXlvFOmsLk%3D 9654596
    • (1998) Pathol Oncol Res , vol.4 , Issue.2 , pp. 115-120
    • Grover-Mckay, M.1    Walsh, S.A.2    Seftor, E.A.3    Thomas, P.A.4    Hendrix, M.J.5
  • 22
    • 0032125565 scopus 로고    scopus 로고
    • GLUT1 glucose transporter expression in colorectal carcinoma: A marker for poor prognosis
    • DOI 10.1002/(SICI)1097-0142(19980701)83:1<34::AID-CNCR5>3.0.CO;2-E
    • RS Haber A Rathan KR Weiser A Pritsker SH Itzkowitz C Bodian G Slater A Weiss DE Burstein 1998 GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis Cancer 83 1 34 40 10.1002/(SICI)1097- 0142(19980701)83:1<34::AID-CNCR5>3.0.CO;2-E 1:CAS:528:DyaK1cXktlejsbw%3D 9655290 (Pubitemid 28299626)
    • (1998) Cancer , vol.83 , Issue.1 , pp. 34-40
    • Haber, R.S.1    Rathan, A.2    Weiser, K.R.3    Pritsker, A.4    Itzkowitz, S.H.5    Bodian, C.6    Slater, G.7    Weiss, A.8    Burstein, D.E.9
  • 23
    • 33846942624 scopus 로고    scopus 로고
    • Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-d-glucose uptake by positron emission tomography in colorectal cancer
    • 10.1007/s10620-006-9428-2 1:CAS:528:DC%2BD2sXktFCktA%3D%3D 17080242
    • J Gu H Yamamoto H Fukunaga K Danno I Takemasa M Ikeda M Tatsumi M Sekimoto J Hatazawa T Nishimura 2006 Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-d-glucose uptake by positron emission tomography in colorectal cancer Dig Dis Sci 51 12 2198 2205 10.1007/s10620-006-9428-2 1:CAS:528:DC%2BD2sXktFCktA%3D%3D 17080242
    • (2006) Dig Dis Sci , vol.51 , Issue.12 , pp. 2198-2205
    • Gu, J.1    Yamamoto, H.2    Fukunaga, H.3    Danno, K.4    Takemasa, I.5    Ikeda, M.6    Tatsumi, M.7    Sekimoto, M.8    Hatazawa, J.9    Nishimura, T.10
  • 24
    • 33845654267 scopus 로고    scopus 로고
    • Evaluation of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in gastric carcinoma: Relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression
    • 10.1007/BF02984657 1:CAS:528:DC%2BD2sXhvFyktrw%3D 17294670
    • A Yamada K Oguchi M Fukushima Y Imai M Kadoya 2006 Evaluation of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression Ann Nucl Med 20 9 597 604 10.1007/BF02984657 1:CAS:528:DC%2BD2sXhvFyktrw%3D 17294670
    • (2006) Ann Nucl Med , vol.20 , Issue.9 , pp. 597-604
    • Yamada, A.1    Oguchi, K.2    Fukushima, M.3    Imai, Y.4    Kadoya, M.5
  • 25
    • 0030160492 scopus 로고    scopus 로고
    • Intratumoral distribution of tritiated-FDG in breast carcinoma: Correlation between Glut-1 expression and FDG uptake
    • 1:STN:280:DyaK28zgtVersw%3D%3D 8683298
    • RS Brown JY Leung SJ Fisher KA Frey SP Ethier RL Wahl 1996 Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake J Nucl Med 37 6 1042 1047 1:STN:280: DyaK28zgtVersw%3D%3D 8683298
    • (1996) J Nucl Med , vol.37 , Issue.6 , pp. 1042-1047
    • Brown, R.S.1    Leung, J.Y.2    Fisher, S.J.3    Frey, K.A.4    Ethier, S.P.5    Wahl, R.L.6
  • 26
    • 0032940031 scopus 로고    scopus 로고
    • Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer
    • 1:STN:280:DyaK1M3isV2iuw%3D%3D 10210213
    • RS Brown JY Leung PV Kison KR Zasadny A Flint RL Wahl 1999 Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer J Nucl Med 40 4 556 565 1:STN:280:DyaK1M3isV2iuw%3D%3D 10210213
    • (1999) J Nucl Med , vol.40 , Issue.4 , pp. 556-565
    • Brown, R.S.1    Leung, J.Y.2    Kison, P.V.3    Zasadny, K.R.4    Flint, A.5    Wahl, R.L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.